Penile and Testicular Cancer: Milan Leading Europe in Rare Male Tumors

From early diagnosis to robotic surgery: the National Cancer Institute sets a benchmark

A European Center of Excellence

Every year, many patients turn to Milan’s National Cancer Institute for the treatment of penile cancer and testicular cancer. Its integrated approach, combining surgery and oncology, ensures patients receive advanced, coordinated, and timely care.

Warning Signs Not to Ignore

Penile cancer, although rare, is increasing, often linked to HPV infection. Symptoms such as painful or bleeding lesions on the glans, urinary difficulties, and swollen lymph nodes should not be ignored.
Testicular cancer has excellent outcomes when detected early: over 90% of patients can recover and live a normal life.

Robotic Surgery and New Treatments

Robotic surgery allows highly precise, minimally invasive operations. Combined with immunotherapy and biologic drugs, it is reshaping the future of male oncological care.

Prevention First

Dr. Tullio Torelli stresses the value of:

  • regular self-examination of the testicles;
  • HPV vaccination;
  • condom use;
  • prompt medical consultation.

Breaking taboos can save lives: in oncology, timing is everything.